These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4904162)

  • 1. Treatment of obese non-diabetic patients with phenformin. A double-blind cross-over trial.
    Hart A; Cohen H
    Br Med J; 1970 Jan; 1(5687):22-4. PubMed ID: 4904162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight-reducing effect of diguanides in obese non-diabetic women.
    Munro JF; MacCuish AC; Marshall A; Wilson EM; Duncan LJ
    Br Med J; 1969 Apr; 2(5648):13-5. PubMed ID: 4887385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
    Abramson E; Arky RA
    Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
    [No Abstract]   [Full Text] [Related]  

  • 4. [An investigation of the effect of biguanides on glucose tolerance and body weight in overweight individuals without diabetes mellitus].
    Frey H
    Tidsskr Nor Laegeforen; 1972 May; 92(15):1036-8. PubMed ID: 4555163
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind study of phenethyldiguanide in weight control of obese nondiabetic subjects.
    Roginsky MS; Barnett J
    Am J Clin Nutr; 1966 Oct; 19(4):223-6. PubMed ID: 5331741
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenformin as an aid to weight reduction.
    Pearson AM; Mather HG
    Br J Clin Pract; 1969 Aug; 23(8):336-8. PubMed ID: 4895653
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of phenformin on “prediabetes”.
    Wilansky DL; Hahn I; Schucher R
    Metabolism; 1965 Jul; 14(7):793-99. PubMed ID: 25286468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenformin in human obesity.
    Roginsky MS; Sandler J
    Ann N Y Acad Sci; 1968 Mar; 148(3):892-6. PubMed ID: 4872313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
    Cabezas Cerrato J; Catalán E; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1973 May; 129(4):337-42. PubMed ID: 4720279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
    Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
    Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
    Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
    Bratusch-Marrain P; Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The lipid reducing action of phenformin in primary type IV hyperlipoproteinaemia (author's transl)].
    Lang PD; Vollmar J; Klemens UH; von Löwis P; Gries FA; Koschinsky T; Huth K; Pilz E; Schlierf G; Kremer GJ; Lenhart P; Schwandt P; Hammerl H; Studlar M
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2280-6. PubMed ID: 4762828
    [No Abstract]   [Full Text] [Related]  

  • 18. Pheniformin in insulin-dependent diabetics.
    Bloom A; Kole RJ
    Br Med J; 1970 Mar; 1(5697):660-2. PubMed ID: 4914612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.
    Salas-Salvadó J; Farrés X; Luque X; Narejos S; Borrell M; Basora J; Anguera A; Torres F; Bulló M; Balanza R;
    Br J Nutr; 2008 Jun; 99(6):1380-7. PubMed ID: 18031592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.